Skip to main content
    B

    Biogen Inc (BIIB)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $250.79
    -0.86 (-0.34%)

    Market Cap: $37.20B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Biogen Inc (BIIB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Biogen (BIIB) has a latest price of $250.79 on Nov 17, 2026, 3.9% below its 52-week high of $261.00. Its price rose 49.7% over the past 12 months. The month-end price fell 9.5% over the 10 years through Oct 2026, a compound annual decline of 1.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $353.49 in Aug 2018 and its lowest $121.08 in Apr 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BIIB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIIB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 13.2%, and over 6 months it rose 31.6%. The month-end price rose 6.8% over the 3 years through Oct 2026, a compound annual rate of 2.2%.

    PeriodChange
    1 month+7.4%
    3 months+13.2%
    6 months+31.6%
    12 months+49.7%
    12 months, with dividends+49.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+6.8%+2.2%
    5 years-4.9%-1.0%
    10 years-9.5%-1.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price rose 15.4%, and its weakest was 2024, when it fell 40.9%.

    YearCloseChange
    2026 through Oct 2026$253.62+44.1%
    2025$175.99+15.1%
    2024$152.92-40.9%
    2023$258.77-6.6%
    2022$276.92+15.4%
    2021$239.92-2.0%
    2020$244.86-17.5%
    2019$296.73-1.4%
    2018$300.92-5.5%
    2017$318.57+12.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.8% above its 50-day average of $234.73 and 21.8% above its 200-day average of $205.87.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$250.79
    52-week high$261.00-3.9%
    52-week low$160.36+56.4%
    50-day average$234.73+6.8%
    200-day average$205.87+21.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 57.7%.

    MeasureValue
    1-year beta0.39
    Largest fall, 1 year-14.3%
    Largest fall, 3 years-57.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Biogen traded at 11.5x earnings at the end of 2025, against a 5-year median of 12.5x and a 10-year median of 12.4x.

    BIIB valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BIIB

    What is BIIB's 1-year price change?

    Biogen's price rose 49.7% over the past 12 months. With dividends included, the 12-month total return was 49.7%.

    What is BIIB's 5-year price change?

    Biogen's month-end price fell 4.9% over the 5 years through Oct 2026, a compound annual decline of 1.0%. These figures leave out dividends.

    What is BIIB's 52-week high and low?

    Biogen's 52-week high is $261.00 and its 52-week low is $160.36. Its latest price of $250.79 on Nov 17, 2026 is 3.9% below the high.

    What is BIIB's beta?

    Biogen's 1-year beta against the S&P 500 is 0.39, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 14.3%.

    Is the BIIB chart free?

    Yes. Advanced Charting for BIIB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.